TherapeuticsMD Inc (TXMD)
1.45
-0.05
(-3.15%)
USD |
NASDAQ |
Nov 14, 16:00
1.45
0.00 (0.00%)
After-Hours: 20:00
TherapeuticsMD Price: 1.45 for Nov. 14, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 13, 2024 | 1.49 | 1.55 | 1.48 | 1.497 | 31151.00 |
Nov 12, 2024 | 1.52 | 1.55 | 1.48 | 1.50 | 25322.00 |
Nov 11, 2024 | 1.55 | 1.551 | 1.50 | 1.52 | 35758.00 |
Nov 08, 2024 | 1.52 | 1.54 | 1.471 | 1.52 | 14434.00 |
Nov 07, 2024 | 1.53 | 1.57 | 1.52 | 1.52 | 14011.00 |
Nov 06, 2024 | 1.55 | 1.58 | 1.534 | 1.54 | 15268.00 |
Nov 05, 2024 | 1.56 | 1.57 | 1.520 | 1.54 | 8645.00 |
Nov 04, 2024 | 1.54 | 1.57 | 1.528 | 1.55 | 11632.00 |
Nov 01, 2024 | 1.55 | 1.55 | 1.52 | 1.549 | 9486.00 |
Oct 31, 2024 | 1.555 | 1.57 | 1.53 | 1.55 | 20111.00 |
Oct 30, 2024 | 1.58 | 1.585 | 1.54 | 1.55 | 19899.00 |
Oct 29, 2024 | 1.58 | 1.60 | 1.56 | 1.57 | 16538.00 |
Oct 28, 2024 | 1.59 | 1.59 | 1.56 | 1.565 | 12101.00 |
Oct 25, 2024 | 1.57 | 1.60 | 1.57 | 1.59 | 8266.00 |
Oct 24, 2024 | 1.60 | 1.60 | 1.57 | 1.58 | 8640.00 |
Oct 23, 2024 | 1.58 | 1.59 | 1.57 | 1.575 | 7963.00 |
Oct 22, 2024 | 1.57 | 1.63 | 1.57 | 1.58 | 13950.00 |
Oct 21, 2024 | 1.62 | 1.62 | 1.56 | 1.575 | 10238.00 |
Oct 18, 2024 | 1.60 | 1.60 | 1.57 | 1.60 | 8115.00 |
Oct 17, 2024 | 1.71 | 1.71 | 1.550 | 1.58 | 40266.00 |
Oct 16, 2024 | 1.59 | 1.59 | 1.53 | 1.58 | 15376.00 |
Oct 15, 2024 | 1.52 | 1.59 | 1.52 | 1.527 | 7535.00 |
Oct 14, 2024 | 1.58 | 1.586 | 1.52 | 1.52 | 15455.00 |
Oct 11, 2024 | 1.58 | 1.62 | 1.56 | 1.58 | 6625.00 |
Oct 10, 2024 | 1.59 | 1.604 | 1.57 | 1.58 | 6097.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.45
Minimum
Nov 14 2024
140.50
Maximum
Jan 21 2020
32.02
Average
9.96
Median
Jun 02 2022
Price Benchmarks
NovaBay Pharmaceuticals Inc | 0.7276 |
Palatin Technologies Inc | 1.07 |
iBio Inc | 2.18 |
Theriva Biologics Inc | 1.365 |
Oragenics Inc | 0.3258 |
Price Related Metrics
PS Ratio | 16.31 |
Price to Book Value | 0.6044 |
Earnings Yield | -36.55% |
Market Cap | 16.72M |